Citations (121)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (6)
Lisa R. LaRowe, John D. Cleveland, Dustin M. Long, Shadi Nahvi, Edward R. Cachay, Katerina A. Christopoulos, Heidi M. Crane, Karen Cropsey, Sonia Napravnik, Conall O’Cleirigh, Jessica S. Merlin & Joseph W. Ditre. (2021) Prevalence and impact of comorbid chronic pain and cigarette smoking among people living with HIV. AIDS Care 33:12, pages 1534-1542.
Read now
Read now
Serena Tonstad, Cynthia Arons, Hans Rollema, Ivan Berlin, Peter Hajek, Karl Fagerström, Charl Els, Thomas McRae & Cristina Russ. (2020) Varenicline: mode of action, efficacy, safety and accumulated experience salient for clinical populations. Current Medical Research and Opinion 36:5, pages 713-730.
Read now
Read now
Kirsi Kautiainen, Heikki Ekroos, Mikko Puhakka, Helena Liira, Juha Laine, Kari Linden & Jarmo Hahl. (2017) Re-treatment with varenicline is a cost-effective aid for smoking cessation. Journal of Medical Economics 20:3, pages 246-252.
Read now
Read now
Lara A. Ray, Kelly E. Courtney, Dara G. Ghahremani, Karen Miotto, Arthur Brody & Edythe D. London. (2015) Varenicline, naltrexone, and their combination for heavy-drinking smokers: preliminary neuroimaging findings. The American Journal of Drug and Alcohol Abuse 41:1, pages 35-44.
Read now
Read now
Eric Druyts, Kristian Thorlund, Samantha Humphreys, Michaela Lion, Curtis L Cooper & Edward J Mills. (2013) Interpreting discordant indirect and multiple treatment comparison meta-analyses: an evaluation of direct acting antivirals for chronic hepatitis C infection. Clinical Epidemiology 5, pages 173-183.
Read now
Read now
Selma Bozkurt Zincir, Serkan Zincir, Esra Kaymak & Esra Aydin Sunbul. (2013) Comparison of the Effectiveness of Varenicline, Extended-Release Bupropion and Nicotine Replacement Therapy on The Success and the Maintenance of a Smoking Cessation Program. Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology 23:3, pages 224-230.
Read now
Read now
Articles from other publishers (115)
Christine Ibrahim, Victor M. Tang, Daniel M. Blumberger, Saima Malik, Rachel Tyndale, Allison Trevizol, Mera S. Barr, Zafiris J. Daskalakis, Abraham Zangen & Bernard Le Foll. (2023) Efficacy of insula deep repetitive transcranial magnetic stimulation combined with varenicline for smoking cessation: A randomized, double-blind, sham controlled trial. Brain Stimulation.
Crossref
Crossref
Saul Shiffman & Michael J. Hannon. (2023) Switching away from smoking at 12 months among adult JUUL users varying in recent history of quit attempts made with and without smoking cessation medication. Drug Testing and Analysis 15:10, pages 1281-1296.
Crossref
Crossref
Carlos Rábade-Castedo, José Ignacio de Granda-Orive, Juan Antonio Riesco-Miranda, Eva De Higes-Martínez, Ángela Ramos-Pinedo, Eva Cabrera-César, Jaime Signes-Costa Miñana, Marcos García Rueda, Esther Pastor-Esplá & Carlos A. Jiménez-Ruiz. (2023) Clinical Practice Guideline of Spanish Society of Pneumology and Thoracic Surgery (SEPAR) on Pharmacological Treatment of Tobacco Dependence 2023. Archivos de Bronconeumología.
Crossref
Crossref
Jonathan Livingstone-Banks, Thomas R Fanshawe, Kyla H Thomas, Annika Theodoulou, Anisa Hajizadeh, Lilian Hartman & Nicola Lindson. (2023) Nicotine receptor partial agonists for smoking cessation. Cochrane Database of Systematic Reviews 2023:6.
Crossref
Crossref
Luba Yammine, Christopher D Verrico, Francesco Versace, Heather E Webber, Robert Suchting, Michael F Weaver, Thomas R Kosten, Husein Alibhai, Paul M Cinciripini, Scott D Lane & Joy M Schmitz. (2023) Exenatide as an adjunct to nicotine patch for smoking cessation and prevention of postcessation weight gain among treatment-seeking smokers with pre-diabetes and/or overweight: study protocol for a randomised, placebo-controlled clinical trial. BMJ Open 13:6, pages e072707.
Crossref
Crossref
Samara J. Vilca, Alexander V. Margetts, Tate A. Pollock & Luis M. Tuesta. (2023) Transcriptional and epigenetic regulation of microglia in substance use disorders. Molecular and Cellular Neuroscience 125, pages 103838.
Crossref
Crossref
R.J. Herman, M.R. Hayes, J. Audrain-McGovern, R.L. Ashare & H.D. Schmidt. (2023) Liraglutide attenuates nicotine self-administration as well as nicotine seeking and hyperphagia during withdrawal in male and female rats. Psychopharmacology 240:6, pages 1373-1386.
Crossref
Crossref
Anisa Hajizadeh, Seth Howes, Annika Theodoulou, Elias Klemperer, Jamie Hartmann-Boyce, Jonathan Livingstone-Banks & Nicola Lindson. (2023) Antidepressants for smoking cessation. Cochrane Database of Systematic Reviews 2023:5.
Crossref
Crossref
Jonathan Livingstone-Banks, Thomas R Fanshawe, Kyla H Thomas, Annika Theodoulou, Anisa Hajizadeh, Lilian Hartman & Nicola Lindson. (2023) Nicotine receptor partial agonists for smoking cessation. Cochrane Database of Systematic Reviews 2023:5.
Crossref
Crossref
Ajinkya Mukadam & Sahana H. Shetiya. (2023) Smoking cessation through nicotine replacement therapy for patients visiting the Dental College, Pune – A quasi-experimental study. Journal of Cancer Research and Therapeutics 19:5, pages 1365-1370.
Crossref
Crossref
Christian Reinhardt, Markus Harden, Christoph Herrmann-Lingen, Achim Rittmeyer & Stefan Andreas. (2022) Smoking cessation by combined medication and counselling: a feasibility study in lung cancer patients. BMC Pulmonary Medicine 22:1.
Crossref
Crossref
Samantha Schiavon, Elizabeth Davies, Sofia Mildrum Chana, Isabel C. Scarinci, Jessica S. Merlin, Jori May & Karen L. Cropsey. (2021) Oncology Patient Smoking Cessation Treatment Preferences: Perceptions Across Former and Current Cigarette Smokers. Journal of Cancer Education 37:6, pages 1975-1981.
Crossref
Crossref
Christopher L. Robinson, Rosa S. Kim, Michael Li, Qing Zhao Ruan, Sindhuja Surapaneni, Mark Jones, Daniel J. Pak & Warren Southerland. (2022) The Impact of Smoking on the Development and Severity of Chronic Pain. Current Pain and Headache Reports 26:8, pages 575-581.
Crossref
Crossref
Jason D. Robinson, Maher Karam‐Hage, George Kypriotakis, Diane Beneventi, Janice A. Blalock, Yong Cui, Roberto Gonzalez, Jean Tayar, Patrick Chaftari & Paul M. Cinciripini. (2022) Bupropion XL and SR have similar effectiveness and adverse event profiles when used to treat smoking among patients at a comprehensive cancer center. The American Journal on Addictions 31:3, pages 236-241.
Crossref
Crossref
Ning Zhu<sup>*+</sup>, Shanhong Lin<sup>*+</sup>, Luyan Dai, Hang Yu, Ning Xu, Weina Huang & Xiaopin Yu. (2022) Abrupt versus gradual smoking cessation with pre-cessation
varenicline therapy for Chinese treatment-seeking smokers:
A retrospective, observational, cohort study. Tobacco Induced Diseases 20:March, pages 1-10.
Crossref
Crossref
Mohammed Al-Hamdani & Eden Manly. (2022) Harm reduction in tobacco control: where do we draw the line?. Journal of Public Health Policy 43:1, pages 149-154.
Crossref
Crossref
Ying Fu, Yu Zhang, Shuang Ju, Bokai Ma, Wenwen Huang & Sulan Luo. (2022) Isolation and characterization of five novel disulfide-poor conopeptides from Conus marmoreus venom. Journal of Venomous Animals and Toxins including Tropical Diseases 28.
Crossref
Crossref
Donna Polk. 2022. Cardiovascular Risk Assessment in Primary Prevention. Cardiovascular Risk Assessment in Primary Prevention
107
121
.
Mehmet KABAK, İclal HOCANLI & Barış ÇİL. (2021) Bir Sigara Bırakma Polikliniğine Başvuran Hastaların ÖzellikleriCharacteristics of Patients Admitted to a Smoking Cessation Policlinic. Harran Üniversitesi Tıp Fakültesi Dergisi 18:3, pages 436-440.
Crossref
Crossref
Daniel J. Devoe, Gina Dimitropoulos, Alida Anderson, Anees Bahji, Jordyn Flanagan, Andrea Soumbasis, Scott B. Patten, Tom Lange & Georgios Paslakis. (2021) The prevalence of substance use disorders and substance use in anorexia nervosa: a systematic review and meta-analysis. Journal of Eating Disorders 9:1.
Crossref
Crossref
Minal Patel, Alison F Cuccia, Yitong Zhou, Elexis C Kierstead, Jodie Briggs & Barbara A Schillo. (2021) Smoking cessation among US adults: use of e-cigarettes, including JUUL, and NRT use. Tobacco Control 30:6, pages 693-695.
Crossref
Crossref
C. Russo, P. Caponnetto, F. Cibella, M. Maglia, A. Alamo, D. Campagna, L. Frittitta, M. Di Mauro, C. Leotta, E. Mondati, A. Krysiński, E. Franek & R. Polosa. (2021) A double blind randomized controlled trial investigating efficacy and safety of varenicline for smoking cessation in patients with type 2 diabetes: study protocol. Internal and Emergency Medicine 16:7, pages 1823-1839.
Crossref
Crossref
Luba Yammine, Charles E Green, Thomas R Kosten, Constanza de Dios, Robert Suchting, Scott D Lane, Christopher D Verrico & Joy M Schmitz. (2021) Exenatide Adjunct to Nicotine Patch Facilitates Smoking Cessation and May Reduce Post-Cessation Weight Gain: A Pilot Randomized Controlled Trial. Nicotine & Tobacco Research 23:10, pages 1682-1690.
Crossref
Crossref
Gideon Katzenberg, Andrew Deacon, Joshua Aigbirior & Jørgen Vestbo. (2021) Management of chronic obstructive pulmonary disease. British Journal of Hospital Medicine 82:7, pages 1-10.
Crossref
Crossref
Archana Mishra, Rituparna Maiti, Biswa Ranjan Mishra & Monalisa Jena. (2021) Comparative efficacy and safety of pharmacological interventions for smoking cessation in healthy adults: A network meta-analysis. Pharmacological Research 166, pages 105478.
Crossref
Crossref
Maria A. Lopez‐Olivo, Jennifer A. Minnix, James G. Fox, Shawn P. E. Nishi, Lisa M. Lowenstein, Kristin G. Maki, Viola B. Leal, Ya‐Chen Tina Shih, Paul M. Cinciripini & Robert J. Volk. (2021) Smoking cessation and shared decision‐making practices about lung cancer screening among primary care providers. Cancer Medicine 10:4, pages 1357-1365.
Crossref
Crossref
Joseph W Ditre, Bryan W Heckman, Lisa R LaRowe & Jessica M Powers. (2021) Pain Status as a Predictor of Smoking Cessation Initiation, Lapse, and Relapse. Nicotine & Tobacco Research 23:1, pages 186-194.
Crossref
Crossref
Federico Giulietti, Andrea Filipponi, Giulia Rosettani, Piero Giordano, Corrado Iacoacci, Francesco Spannella & Riccardo Sarzani. (2020) Pharmacological Approach to Smoking Cessation: An Updated Review for Daily Clinical Practice. High Blood Pressure & Cardiovascular Prevention 27:5, pages 349-362.
Crossref
Crossref
Lisa R. LaRowe & Joseph W. Ditre. (2020) Pain, nicotine, and tobacco smoking: current state of the science. Pain 161:8, pages 1688-1693.
Crossref
Crossref
C A Jiménez-Ruiz, V Martín, X Alsina-Restoy, J I Granda-Orive, E de Higes-Martínez, M García-Rueda, M Genovés-Crespo, C López-García, J J Lorza-Blasco, F L Márquez, Á Ramos-Pinedo, J A Riesco-Miranda, J Signes-Costa, S Solano-Reina, P Vaquero-Lozano & J Rejas. (2020) Cost–benefit analysis of funding smoking cessation before surgery. British Journal of Surgery 107:8, pages 978-994.
Crossref
Crossref
Shuilian Chu, Lirong Liang, Hang Jing, Di Zhang & Zhaohui Tong. (2020) Safety of varenicline as an aid to smoking cessation in
professional drivers and its impact on driving behaviors:
An observational cohort study of taxi drivers in Beijing. Tobacco Induced Diseases 18:May.
Crossref
Crossref
Seth Howes, Jamie Hartmann-Boyce, Jonathan Livingstone-Banks, Bosun Hong & Nicola Lindson. (2020) Antidepressants for smoking cessation. Cochrane Database of Systematic Reviews 2021:5.
Crossref
Crossref
Matthew Evison, Cheryl Pearse, Freya Howle, Monique Baugh, Helen Huddart, Eileen Ashton, Michael Rutherford, Carol Kearney, Lyn Elsey, Darren Staniforth, Kathryn Hoyle, Murugesan Raja, Julie Jerram, David Regan, Richard Booton, John Britton, Claire O'Rourke, David Shackley, Liz Benbow, Andrea Crossfield, Jayne Pilkington, Mandy Bailey & Richard Preece. (2020) Feasibility, uptake and impact of a hospital-wide tobacco addiction treatment pathway: Results from the CURE project pilot. Clinical Medicine 20:2, pages 196-202.
Crossref
Crossref
Shahida Shahrir, Kristina Crothers, Kathleen A. McGinnis, Kwun C.G. Chan, Jared M. Baeten, Sarah M. Wilson, Adeel A. Butt, Margaret A. Pisani, Stephen R. Baldassarri, Amy Justice & Emily C. Williams. (2020) Receipt and predictors of smoking cessation pharmacotherapy among veterans with and without HIV. Progress in Cardiovascular Diseases 63:2, pages 118-124.
Crossref
Crossref
Robert Philibert, Meeshanthini Dogan, Steven R. H. Beach, James A. Mills & Jeffrey D. Long. (2019) AHRR methylation predicts smoking status and smoking intensity in both saliva and blood DNA. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 183:1, pages 51-60.
Crossref
Crossref
D. Campagna, A. Alamo, A. Di Pino, C. Russo, A. E. Calogero, F. Purrello & R. Polosa. (2019) Smoking and diabetes: dangerous liaisons and confusing relationships. Diabetology & Metabolic Syndrome 11:1.
Crossref
Crossref
Javier Rejas-Gutiérrez, Alejandra López-Ibáñez de Aldecoa, Marisol Casasola, Pilar Varela, Sebastiana Quesada, Victoria Olive & Encarnación Arriaza. (2019) Economic Evaluation of Combining Pharmaco- and Behavioral Therapies for Smoking Cessation in an Occupational Medicine Setting. Journal of Occupational & Environmental Medicine 61:4, pages 318-327.
Crossref
Crossref
Davide Campagna, Angela Alamo, Enrico Mondati & Riccardo Polosa. (2019) DIABETE, TABAGISMO E DISASSUEFAZIONE DAL FUMO. il Diabete 31:N. 1, marzo 2019, pages 41-52.
Crossref
Crossref
Nan Xia, Afsaneh Morteza, Fengyu Yang, Hong Cao & Aiping Wang. (2019) Review of the role of cigarette smoking in diabetic foot. Journal of Diabetes Investigation 10:2, pages 202-215.
Crossref
Crossref
Nurgul Bozkurt, Fatih Altıntas, Ali Ihsan Bozkurt, Gunfer Turgut & Sebahat Turgut. (2019) Effect of MDR C3435T polymorphism on Varenicline treatment in quit smoking. Brazilian Journal of Pharmaceutical Sciences 55.
Crossref
Crossref
Yoong Mei Theng, Suzaily Wahab, Noor Alaudin A. Wahab, Hatta Sidi & Srijit Das. (2018) Schizophrenia and Nicotine Dependence: What Psychopharmacological Treatment Options are Available for the Duo Perturbationes?. Current Drug Targets 20:2, pages 173-181.
Crossref
Crossref
Neil Walker, Yaling Yang, Vasiliki Kiparoglou, Subhash Pokhrel, Hayley Robinson & Hugo van Woerden. (2018) An examination of user costs in relation to smokers using a cessation service based in the UK. BMC Health Services Research 18:1.
Crossref
Crossref
Rafael J. Hernández Zenteno, Danitza Fernández Lara, Alejandra Ramírez Venegas, Raúl H. Sansores, Justino Regalado Pineda, Fernando Flores Trujillo, José Rogelio Pérez Padilla, Maria Gabriela Matera & Mario Cazzola. (2018) Varenicline for long term smoking cessation in patients with COPD. Pulmonary Pharmacology & Therapeutics 53, pages 116-120.
Crossref
Crossref
Fernea Moyo, Ella Archibald & Jason T. Slyer. (2018) Effectiveness of decision aids for smoking cessation in adults: a quantitative systematic review. JBI Database of Systematic Reviews and Implementation Reports 16:9, pages 1791-1822.
Crossref
Crossref
Paul M. Cinciripini, Jennifer A. Minnix, Charles E. Green, Jason D. Robinson, Jeffrey M. Engelmann, Francesco Versace, David W. Wetter, Sanjay Shete & Maher Karam-Hage. (2018) An RCT with the combination of varenicline and bupropion for smoking cessation: clinical implications for front line use. Addiction 113:9, pages 1673-1682.
Crossref
Crossref
Jesse D. Kosiba, Emily L. Zale & Joseph W. Ditre. (2018) Associations between pain intensity and urge to smoke: Testing the role of negative affect and pain catastrophizing. Drug and Alcohol Dependence 187, pages 100-108.
Crossref
Crossref
Li-Shiun Chen, Laurie Zawertailo, Thomas M Piasecki, Jaakko Kaprio, Marilyn Foreman, Hannah R Elliott, Sean P David, Andrew W Bergen, James W Baurley, Rachel F Tyndale, Timothy B Baker, Laura J Bierut & Nancy L Saccone. (2018) Leveraging Genomic Data in Smoking Cessation Trials in the Era of Precision Medicine: Why and How. Nicotine & Tobacco Research 20:4, pages 414-424.
Crossref
Crossref
Maher Karam-HageGeorge KypriotakisJason D. RobinsonCharles E. GreenGurtej MannVance RabiusRosario WippoldJanice A. BlalockElie MouhayarJean TayarPatrick ChaftariPaul M. Cinciripini. (2018) Improvement of Smoking Abstinence Rates With Increased Varenicline Dosage. Journal of Clinical Psychopharmacology 38:1, pages 34-41.
Crossref
Crossref
Luba Yammine, Thomas R. Kosten, Paul M. Cinciripini, Charles E. Green, Janet C. Meininger, Jennifer A. Minnix & Thomas F. Newton. (2018) Exenatide once weekly for smoking cessation. Medicine 97:2, pages e9567.
Crossref
Crossref
Christina A Brezing & Frances R Levin. (2017) The Current State of Pharmacological Treatments for Cannabis Use Disorder and Withdrawal. Neuropsychopharmacology 43:1, pages 173-194.
Crossref
Crossref
Roberto Secades-Villa, Alba González-Roz, Ángel García-Pérez & Elisardo Becoña. (2017) Psychological, pharmacological, and combined smoking cessation interventions for smokers with current depression: A systematic review and meta-analysis. PLOS ONE 12:12, pages e0188849.
Crossref
Crossref
Fernea Moyo, Ella Archibald & Jason T. Slyer. (2017) Effectiveness of decision aids on smoking cessation in adult patients: a systematic review protocol. JBI Database of Systematic Reviews and Implementation Reports 15:12, pages 2881-2889.
Crossref
Crossref
Ewoud Schuit, Orestis A. Panagiotou, Marcus R Munafò, Derrick A Bennett, Andrew W Bergen & Sean P David. (2017) Pharmacotherapy for smoking cessation: effects by subgroup defined by genetically informed biomarkers. Cochrane Database of Systematic Reviews 2018:2.
Crossref
Crossref
Darryl P. LeongPhilip G. JosephMartin McKeeSonia S. AnandKoon K. TeoJon-David SchwalmSalim Yusuf. (2017) Reducing the Global Burden of Cardiovascular Disease, Part 2. Circulation Research 121:6, pages 695-710.
Crossref
Crossref
Paul M. Cinciripini, Charles E. Green, Jason D. Robinson, Maher Karam-Hage, Jeffrey M. Engelmann, Jennifer A. Minnix, David W. Wetter & Francesco Versace. (2017) Benefits of varenicline vs. bupropion for smoking cessation: a Bayesian analysis of the interaction of reward sensitivity and treatment. Psychopharmacology 234:11, pages 1769-1779.
Crossref
Crossref
Amy Guzik & Cheryl Bushnell. (2017) Stroke Epidemiology and Risk Factor Management. CONTINUUM: Lifelong Learning in Neurology 23:1, pages 15-39.
Crossref
Crossref
Claudio Lucchiari, Marianna Masiero, Andrea Botturi & Gabriella Pravettoni. (2016) Helping patients to reduce tobacco consumption in oncology: a narrative review. SpringerPlus 5:1.
Crossref
Crossref
Heather E. Tulloch, Andrew L. Pipe, Charl Els, Matthew J. Clyde & Robert D. Reid. (2016) Flexible, dual-form nicotine replacement therapy or varenicline in comparison with nicotine patch for smoking cessation: a randomized controlled trial. BMC Medicine 14:1.
Crossref
Crossref
N. J. Walker, H. C. van Woerden, V. Kiparoglou, Y. Yang, H. Robinson & E. Croghan. (2016) Gender difference and effect of pharmacotherapy: findings from a smoking cessation service. BMC Public Health 16:1.
Crossref
Crossref
Po-Yin Chang, Po-Ching Lo, Hui-Chin Chang, Kuang-Chieh Hsueh & Yi-Wen Tsai. (2016) Comparative Effectiveness of Smoking Cessation Medications: A National Prospective Cohort From Taiwan. PLOS ONE 11:11, pages e0166992.
Crossref
Crossref
Mark M. Levandoski & Sivaramakrishna Koganti. 2016. Allosterism in Drug Discovery. Allosterism in Drug Discovery
334
359
.
Emma Beard, Lion Shahab, Damian M. Cummings, Susan Michie & Robert West. (2016) New Pharmacological Agents to Aid Smoking Cessation and Tobacco Harm Reduction: What Has Been Investigated, and What Is in the Pipeline?. CNS Drugs 30:10, pages 951-983.
Crossref
Crossref
Molly McCarthy, Mohammad Siahpush, Raees A. Shaikh, Asia Sikora Kessler & Melissa Tibbits. (2016) Social Disparities in Unaided Quit Attempts Among Daily Current and Former Smokers: Results From the 2010?2011 Tobacco Use Supplement to the Current Population Survey. Nicotine & Tobacco Research 18:8, pages 1705-1710.
Crossref
Crossref
Joseph W. Ditre, Bryan W. Heckman, Emily L. Zale, Jesse D. Kosiba & Stephen A. Maisto. (2016) Acute analgesic effects of nicotine and tobacco in humans: a meta-analysis. Pain 157:7, pages 1373-1381.
Crossref
Crossref
Joseph W. Ditre, Jesse D. Kosiba, Emily L. Zale, Michael J. Zvolensky & Stephen A. Maisto. (2016) Chronic Pain Status, Nicotine Withdrawal, and Expectancies for Smoking Cessation Among Lighter Smokers. Annals of Behavioral Medicine 50:3, pages 427-435.
Crossref
Crossref
Kate Cahill, Nicola Lindson-Hawley, Kyla H Thomas, Thomas R Fanshawe & Tim Lancaster. (2016) Nicotine receptor partial agonists for smoking cessation. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Halley E.M. Riley, Erin Berry-Bibee, Lucinda J. England, Denise J. Jamieson, Polly A. Marchbanks & Kathryn M. Curtis. (2016) Hormonal contraception among electronic cigarette users and cardiovascular risk: a systematic review. Contraception 93:3, pages 190-208.
Crossref
Crossref
Daniel J. O. Roche, Lara A. Ray, Megan M. Yardley & Andrea C. King. (2016) Current Insights into the Mechanisms and Development of Treatments for Heavy-Drinking Cigarette Smokers. Current Addiction Reports 3:1, pages 125-137.
Crossref
Crossref
Ping-Hsun Chang, Chien-Hsieh Chiang, Wei-Che Ho, Pei-Zu Wu, Jaw-Shiun Tsai & Fei-Ran Guo. (2015) Combination therapy of varenicline with nicotine replacement therapy is better than varenicline alone: a systematic review and meta-analysis of randomized controlled trials. BMC Public Health 15:1.
Crossref
Crossref
Carrie D. PatnodeJillian T. HendersonJamie H. ThompsonCaitlyn A. SengerStephen P. FortmannEvelyn P. Whitlock. (2015) Behavioral Counseling and Pharmacotherapy Interventions for Tobacco Cessation in Adults, Including Pregnant Women: A Review of Reviews for the U.S. Preventive Services Task Force. Annals of Internal Medicine 163:8, pages 608-621.
Crossref
Crossref
Megan M. Yardley, Michael M. Mirbaba & Lara A. Ray. (2015) Pharmacological Options for Smoking Cessation in Heavy-Drinking Smokers. CNS Drugs 29:10, pages 833-845.
Crossref
Crossref
Anand R. Shewale, Mrudula S. Borse, Joshua D. Brown & Chenghui Li. (2015) Mental health status of varenicline and bupropion users during a quit attempt compared to current smokers, other quitters, and non-smokers. Drug and Alcohol Dependence 154, pages 132-138.
Crossref
Crossref
F. Cuny, E. Babin, J. Lacau-Saint-Guily, B. Baujat, R. Bensadoun, A. Bozec, D. Chevalier, O. Choussy, S. Deneuve, N. Fakhry, J. Guigay, M. Makeieff, J.-C. Merol, F. Mouawad, J. Pavillet, C. Rebiere, C. Righini, M.-C. Sostras, M. Tournaille & S. Vergez. (2015) French Society of ENT (SFORL) guidelines for care pathway organization in head and neck oncology (short version). Early management of head and neck cancer. European Annals of Otorhinolaryngology, Head and Neck Diseases 132:4, pages 205-208.
Crossref
Crossref
F. Cuny, E. Babin, J. Lacau Saint Guily, B. Baujat, R. Bensadoun, A. Bozec, D. Chevalier, O. Choussy, S. Deneuve, N. Fakhry, J. Guigay, M. Makeieff, J.-C. Merol, F. Mouawad, J. Pavillet, C. Rebiere, C. Righini, M.-C. Sostras, M. Tournaille & S. Vergez. (2015) Recommandation de la SFORL sur l?organisation du parcours de soins en canc?rologie des voies a?ro-digestives sup?rieures (version courte). Prise en charge pr?coce des patients porteurs d?un cancer de la t?te et du cou. Annales fran?aises d'Oto-rhino-laryngologie et de Pathologie Cervico-faciale 132:4, pages 191-195.
Crossref
Crossref
Graham Cope. (2015) Smoking and the risk of tuberculosis treatment failure. Practice Nursing 26:8, pages 374-377.
Crossref
Crossref
Clary J. Foote, Harman Chaudhry, Mohit Bhandari, Lehana Thabane, Toshi A. Furukawa, Brad Petrisor & Gordon Guyatt. (2015) Network Meta-analysis: Users’ Guide for Surgeons: Part I - Credibility. Clinical Orthopaedics & Related Research 473:7, pages 2166-2171.
Crossref
Crossref
Robert Philibert, Nancy Hollenbeck, Eleanor Andersen, Terry Osborn, Meg Gerrard, Frederick X. Gibbons & Kai Wang. (2015) A quantitative epigenetic approach for the assessment of cigarette consumption. Frontiers in Psychology 6.
Crossref
Crossref
Gernot Fugger, Rebekka Jung & Martin Aigner. (2015) Psychoedukationsgruppen f?r Raucherentw?hnung auf einer akutpsychiatrischen AbteilungPsychoeducational Smoking Cessation Groups in an Acute Psychiatry Ward. neuropsychiatrie 29:2, pages 88-92.
Crossref
Crossref
Shu-Chun Hsueh, Kuang-Chieh Hsueh, Ming-Yueh Chou & Ming-Shium Tu. (2012) A Comparison of the Effectiveness of Varenicline and Transdermal Nicotine Patch in Outpatients Following a Standardized Smoking Cessation Program in Southern Taiwan. Evaluation & the Health Professions 38:1, pages 115-125.
Crossref
Crossref
Xiomara A. Perez, Taline V. Khroyan, J. Michael McIntosh & Maryka Quik. (2014) Varenicline enhances dopamine release facilitation more than nicotine after long‐term nicotine treatment and withdrawal. Pharmacology Research & Perspectives 3:1.
Crossref
Crossref
Chang Dong YeoHea Yeon LeeJick Hwan HaHyeon Hui KangJi Young KangSung Kyoung KimMyung Sook KimHwa Sik MoonSang Haak Lee. (2015) Efficacy of Team-Based Financial Incentives for Smoking Cessation in the Workplace. Yonsei Medical Journal 56:1, pages 295.
Crossref
Crossref
Debasish Basu, Sukanya Mitra & Nalini Vadivelu. 2015. Substance Abuse. Substance Abuse
89
107
.
Robert A. Goldberg & Daniel B. Rootman. 2015. Thyroid Eye Disease. Thyroid Eye Disease
127
142
.
Massimiliano Buoli, Claudia Cumerlato Melter, Alice Caldiroli & A. Carlo Altamura. (2015) Are antidepressants equally effective in the long-term treatment of major depressive disorder?. Human Psychopharmacology: Clinical and Experimental 30:1, pages 21-27.
Crossref
Crossref
Josep M Ramon, Sergio Morchon, Antoni Baena & Cristina Masuet-Aumatell. (2014) Combining varenicline and nicotine patches: a randomized controlled trial study in smoking cessation. BMC Medicine 12:1.
Crossref
Crossref
Elif Yilmazel Ucar, Omer Araz, Nafiye Yilmaz, Metin Akgun, Mehmet Meral, Hasan Kaynar & Leyla Saglam. (2014) Effectiveness of pharmacologic therapies on smoking cessation success: three years results of a smoking cessation clinic. Multidisciplinary Respiratory Medicine 9:1.
Crossref
Crossref
Michelle Johnson, Pippa Anderson & Ian Lockhart. (2014) General practitioner prescribing of single and combination nicotine replacement therapy in the UK: a retrospective database study. BMC Family Practice 15:1.
Crossref
Crossref
James F. Meschia, Cheryl Bushnell, Bernadette Boden-Albala, Lynne T. Braun, Dawn M. Bravata, Seemant Chaturvedi, Mark A. Creager, Robert H. Eckel, Mitchell S.V. Elkind, Myriam Fornage, Larry B. Goldstein, Steven M. Greenberg, Susanna E. Horvath, Costantino Iadecola, Edward C. Jauch, Wesley S. Moore & John A. Wilson. (2014) Guidelines for the Primary Prevention of Stroke. Stroke 45:12, pages 3754-3832.
Crossref
Crossref
Ayşegül Yildiz, Eduard Vieta, Christoph U. Correll, Mateusz Nikodem & Ross J. Baldessarini. (2014) Critical Issues on the Use of Network Meta-analysis in Psychiatry. Harvard Review of Psychiatry 22:6, pages 367-372.
Crossref
Crossref
Lara A. Ray, Kelly E. Courtney, Dara G. Ghahremani, Karen Miotto, Arthur Brody & Edythe D. London. (2014) Varenicline, low dose naltrexone, and their combination for heavy-drinking smokers: human laboratory findings. Psychopharmacology 231:19, pages 3843-3853.
Crossref
Crossref
Yohalakshmi Chelladurai & Sonal Singh. (2014) Varenicline and cardiovascular adverse events: a perspective review. Therapeutic Advances in Drug Safety 5:4, pages 167-172.
Crossref
Crossref
Kelly L. Kandra, Leah M. Ranney, Joseph G. L. Lee & Adam O. Goldstein. (2014) Physicians’ Attitudes and Use of E-Cigarettes as Cessation Devices, North Carolina, 2013. PLoS ONE 9:7, pages e103462.
Crossref
Crossref
Maher Karam-Hage, Paul M. Cinciripini & Ellen R. Gritz. (2014) Tobacco use and cessation for cancer survivors: An overview for clinicians. CA: A Cancer Journal for Clinicians 64:4, pages 272-290.
Crossref
Crossref
Heather Tulloch, Andrew Pipe, Charl Els, Debbie Aitken, Matthew Clyde, Brigitte Corran & Robert D. Reid. (2014) Flexible and extended dosing of nicotine replacement therapy or varenicline in comparison to fixed dose nicotine replacement therapy for smoking cessation: Rationale, methods and participant characteristics of the FLEX trial. Contemporary Clinical Trials 38:2, pages 304-313.
Crossref
Crossref
Paul A. Chrisman, Julie I. Podair, Emily M. Jobe & Mark M. Levandoski. (2014) Intra-subunit flexibility underlies activation and allosteric modulation of neuronal nicotinic acetylcholine receptors. Neuropharmacology 79, pages 420-431.
Crossref
Crossref
Bengt Järvholm & Ingemar Bohlin. (2014) Evidence-based evaluation of information: The centrality and limitations of systematic reviews. Scandinavian Journal of Public Health 42:13_suppl, pages 3-10.
Crossref
Crossref
Henri-Jean Aubin, Amandine Luquiens & Ivan Berlin. (2014) Pharmacotherapy for smoking cessation: pharmacological principles and clinical practice. British Journal of Clinical Pharmacology 77:2, pages 324-336.
Crossref
Crossref
Edward J. MillsKristian ThorlundShawn EapenPing WuJudith J. Prochaska. (2014) Cardiovascular Events Associated With Smoking Cessation Pharmacotherapies. Circulation 129:1, pages 28-41.
Crossref
Crossref
Folasade M. Kolade. (2014) Tennessee Health Plan Tobacco Cessation Coverage. Public Health Nursing 31:1, pages 28-35.
Crossref
Crossref
Kenneth A. Perkins & Caryn Lerman. (2013) An efficient early phase 2 procedure to screen medications for efficacy in smoking cessation. Psychopharmacology 231:1, pages 1-11.
Crossref
Crossref
Alberto de Hoyos & Malcolm DeCamp. 2014. Difficult Decisions in Thoracic Surgery. Difficult Decisions in Thoracic Surgery
85
98
.
Kristian Thorlund, Lehana Thabane & Edward J Mills. (2013) Modelling heterogeneity variances in multiple treatment comparison meta-analysis – Are informative priors the better solution?. BMC Medical Research Methodology 13:1.
Crossref
Crossref
Denise Campbell-Scherer. (2013) Multitreatment comparison meta-analysis: promise and peril. Evidence Based Medicine 18:6, pages 201-203.
Crossref
Crossref
Xiomara A. Perez, J.Michael McIntosh & Maryka Quik. (2013) Long-term nicotine treatment down-regulates α6β2* nicotinic receptor expression and function in nucleus accumbens. Journal of Neurochemistry 127:6, pages 762-771.
Crossref
Crossref
Guy A. Higgins, Edward M. Sellers & Paul J. Fletcher. (2013) From obesity to substance abuse: therapeutic opportunities for 5-HT2C receptor agonists. Trends in Pharmacological Sciences 34:10, pages 560-570.
Crossref
Crossref
B. Amores Arriaga, J. Cebollada del Hoyo, M.P. Gonz?lez Garc?a & J.I. P?rez Calvo. (2013) Tratamiento de los factores de riesgo vascular y objetivos terap?uticos. Medicine - Programa de Formaci?n M?dica Continuada Acreditado 11:40, pages 2410-2419.
Crossref
Crossref
L. Lo Russo & G. Pizzo. (2013) Fumo, alcol e salute orale. Dental Cadmos 81:8, pages 486-503.
Crossref
Crossref
Eva Kralikova, Alexandra Kmetova, Lenka Stepankova, Kamila Zvolska, Rachel Davis & Robert West. (2013) Fifty-two-week continuous abstinence rates of smokers being treated with varenicline versus nicotine replacement therapy. Addiction 108:8, pages 1497-1502.
Crossref
Crossref
Sean P David, Tim Lancaster, Lindsay F Stead, A. Eden Evins & Judith J Prochaska. (2013) Opioid antagonists for smoking cessation. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Anta Ngkelo & Ian M Adcock. (2013) New treatments for COPD. Current Opinion in Pharmacology 13:3, pages 362-369.
Crossref
Crossref
Kate Cahill, Sarah Stevens, Rafael Perera & Tim Lancaster. (2013) Pharmacological interventions for smoking cessation: an overview and network meta-analysis. Cochrane Database of Systematic Reviews 2015:7.
Crossref
Crossref
Leonie S. Brose, Robert West & John A. Stapleton. (2013) Comparison of the Effectiveness of Varenicline and Combination Nicotine Replacement Therapy for Smoking Cessation in Clinical Practice. Mayo Clinic Proceedings 88:3, pages 226-233.
Crossref
Crossref
. 2013. Complications et S?quelles des Traitements en Canc?rologie ORL. Complications et S?quelles des Traitements en Canc?rologie ORL
149
163
.
Kristian Thorlund & Edward J Mills. (2012) Sample size and power considerations in network meta-analysis. Systematic Reviews 1:1.
Crossref
Crossref
Mark Greener. (2012) Varenicline improves quitting rates. Nurse Prescribing 10:9, pages 453-453.
Crossref
Crossref